Suchergebnisse - "Enomoto, Takayuki"

PubPharm (629)

31

Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer : a JSGO-JSOG joint study

enthalten in: Journal of gynecologic oncology | 2023

von Seino, M. | Nagase, S. | Ohta, T. | +7

32

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer : a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

enthalten in: International journal of clinical oncology | 2023

von Mizuno, M. | Ito, K. | Nakai, H. | +18

33

Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer

enthalten in: Cancer science | 2023

von Oda, K. | Aoki, D. | Tsuda, H. | +5

34

Comparison of older and younger patients with ovarian cancer : A post hoc study ( JGOG3016‐A3) of the treatment strength and prognostic outcomes of conventional or dose‐dense chemotherapy

enthalten in: Journal of Obstetrics and Gynaecology Research | 2023

von Itani, Y. | Sakai, H. | Hamano, T. | +7

35

The efficacy of human papillomavirus vaccination in young Japanese girls : the interim results of the OCEAN study

enthalten in: Human vaccines & immunotherapeutics | 2022

von Hiramatsu, K. | Ueda, Y. | Yagi, A. | +26

36

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

enthalten in: International journal of clinical oncology | 2022

von Mizuno, M. | Ito, K. | Nakai, H. | +18

37

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

enthalten in: International journal of clinical oncology | 2022

von Mizuno, M. | Ito, K. | Nakai, H. | +18

38

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

enthalten in: International journal of clinical oncology | 2022

von Mizuno, M. | Ito, K. | Nakai, H. | +18

39

Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer : analysis of a Japanese healthcare claims database

enthalten in: Journal of gynecologic oncology | 2022

von Ueda, A. | Watari, H. | Mandai, M. | +5

40

Factor structure of the parental bonding instrument for pregnant Japanese women

enthalten in: Scientific reports | 2022

von Fukui, N. | Watanabe, Y. | Hashijiri, K. | +5